AU Patent

AU656551B2 — Angiotensin II receptor blocking compositions

Assigned to SmithKline Beecham Corp · Expires 1995-02-09 · 31y expired

What this patent protects

This invention relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier, an angiotensin II receptor antagonist and a second agent selected from a diuretic, a calcium channel blocker, a beta -adrenoceptor blocker, a renin inhibitor, or an angiotensi…

USPTO Abstract

This invention relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier, an angiotensin II receptor antagonist and a second agent selected from a diuretic, a calcium channel blocker, a beta -adrenoceptor blocker, a renin inhibitor, or an angiotensin converting enzyme inhibitor and a method of treating hypertension.

Drugs covered by this patent

Patent Metadata

Patent number
AU656551B2
Jurisdiction
AU
Classification
—
Expires
1995-02-09
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.